Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and losartan potassium

tolvaptan has been researched along with losartan potassium in 3 studies

Compound Research Comparison

Studies
(tolvaptan)		Trials
(tolvaptan)		Recent Studies (post-2010)
(tolvaptan)		Studies
(losartan potassium)		Trials
(losartan potassium)		Recent Studies (post-2010) (losartan potassium)
96717278624,3902,4935,408

Protein Interaction Comparison

ProteinTaxonomytolvaptan (IC50)losartan potassium (IC50)
Bile salt export pumpHomo sapiens (human)8.53
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0082
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0049
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0082
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0082
Type-1 angiotensin II receptorCavia porcellus (domestic guinea pig)0.018

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Harman, C1
Achtari Jeanneret, L; Barras-Moret, AC; Carron, P; Deriaz-Chessex, S; Donzé, J; Fournier, Y; Gachoud, D; Moix, PA; Monti, M; Rossier, A; Wilson, P1

Other Studies

3 other study(ies) available for tolvaptan and losartan potassium

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
What new drugs can nephrologists look forward to in the next year or two?
    Nature clinical practice. Nephrology, 2007, Volume: 3, Issue:5

    Topics: Amides; Anemia; Antihypertensive Agents; Benzazepines; Drug Administration Schedule; Drug Approval; Drug Combinations; Drug Delivery Systems; Erythropoietin; Ferrosoferric Oxide; Fumarates; Humans; Hyponatremia; Immunosuppressive Agents; Kidney Diseases; Nanoparticles; Nephrology; Renal Dialysis; Renin; Tacrolimus; Tolvaptan

2007
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
    Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142

    Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload

2008